Work

Pos0033 Health-related Quality of Life (hrqol) and Other Secondary Clinical Outcomes in Adults With Gout Refractory to Conventional Therapy Treated With Sel-212: Pooled 6-month Data From the Phase 3 Dissolve I & Ii Clinical Trials

Year: 2024

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2024-eular.2872

Authors: P. Khanna, A. Patel, A. Singhal, A. Kivitz, J. Sobierska, H. Santin-Janin, N. Kragh, R. Azeem, W. Dehaan, P. Traber, H.S.B. Baraf

Institutions: University of Michigan, Altoona Center for Clinical Research, George Washington University

Language: English

Topic: Gout, Hyperuricemia, Uric Acid

Subfield: Nephrology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4399481863

Cites:

Cited by: 1

Related to: 10